Biotech

By Beatrice NolanJuly 18, 2025

By Howard DeanJune 10, 2025

Tech‘This is not Theranos 2.0′: Elizabeth Holmes’ partner is the CEO behind new blood-testing startup
By Beatrice NolanMay 12, 2025

CommentaryWhy federal funding for life sciences—now being slashed—is a strategic necessity for America
By Tiffany WilsonApril 17, 2025

TechExclusive: Biotech startup Profluent says it has discovered AI ‘scaling laws’ for AI models used in protein design
By Jeremy KahnApril 16, 2025

FeaturesWill AI ever cure cancer? The multibillion-dollar race to bring the first AI-discovered drug to market
By Erika FryApril 3, 2025

TechAs a kid, she raised money to cure cystic fibrosis. Now she’s the CEO of a $2.6 billion genetic testing company
By Andrew NuscaMarch 31, 2025

By Alexa Mikhail and Beth GreenfieldMarch 24, 2025

Tech23andMe users told to consider deleting their data by California attorney general as the company files for bankruptcy
By Beatrice NolanMarch 24, 2025

LifeThis company is launching a genetic matching feature for future parents—and the CEO says ‘it has nothing to do with eugenics’
By Alexa MikhailMarch 23, 2025

By Michelle WernerMarch 10, 2025

LeadershipA few years ago 23andMe was worth $6 billion. Now CEO Anne Wojcicki is trying to buy it back for $42 million
By Lila MacLellanMarch 1, 2025
Most Popular





